Skip to main content
Top
Published in: International Journal of Legal Medicine 1/2016

01-01-2016 | Review

The pharmacology and toxicology of kratom: from traditional herb to drug of abuse

Authors: Marcus L. Warner, Nellie C. Kaufman, Oliver Grundmann

Published in: International Journal of Legal Medicine | Issue 1/2016

Login to get access

Abstract

Mitragyna speciosa (Rubiaceae), commonly known as kratom, is a tropical tree with a long history of traditional use in parts of Africa and Southeast Asia. In recent years, kratom has gained popularity for use as a recreational drug across the globe. Relatively new to the illicit market and used in a manner different from its traditional applications, preparations of kratom are touted by many as a safe and legal psychoactive product that improves mood, relieves pain, and may provide benefits in opiate addiction. Available literature was reviewed for M. speciosa via PubMed, Google Scholar, CINAHL, and EBSCO to summarize its traditional uses, phytochemical composition, pharmacology and toxicology of proposed active constituents, and potential for misuse and abuse. Research has demonstrated that both stimulant and sedative dose-dependent effects do exist, but a growing concern for the drug’s effects and safety of use has resulted in national and international attention primarily due to an increase in hospital visits and deaths in several countries that are said to have been caused by extracts of the plant. The main active alkaloid substances in kratom, mitragynine and 7-hydroxymitragynine, present with a range of CNS stimulant and depressant effects mediated primarily through monoaminergic and opioid receptors. Recently, Palm Beach County, located in the southeastern corridor of Florida, has considered regulating kratom due to public safety concerns following the death of a young adult. At the local, state, and even federal levels, governments are now being confronted with the task of determining the safety and the possible regulation of kratom extracts. There are currently no standard analytical screening techniques for mitragynine and its metabolites following ingestion limiting its detection to more sophisticated techniques like liquid chromatography-mass spectrometry to determine kratom use. The growing concern of the abuse potential of kratom requires careful evaluation of its benefits and potential toxicities.
Literature
1.
go back to reference Richardson WH 3rd, Slone CM, Michels JE (2007) Herbal drugs of abuse: an emerging problem. Emerg Med Clin North Am 25(2):435–457CrossRef Richardson WH 3rd, Slone CM, Michels JE (2007) Herbal drugs of abuse: an emerging problem. Emerg Med Clin North Am 25(2):435–457CrossRef
2.
go back to reference Jerry J, Collins G, Streem D (2012) Synthetic legal intoxicating drugs: the emerging ‘incense’ and ‘bath salt’ phenomenon. Cleve Clin J Med 79:258–264CrossRef Jerry J, Collins G, Streem D (2012) Synthetic legal intoxicating drugs: the emerging ‘incense’ and ‘bath salt’ phenomenon. Cleve Clin J Med 79:258–264CrossRef
3.
go back to reference Rosenbaum CD, Carreiro SP, Babu KM (2012) Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 8:15–32CrossRef Rosenbaum CD, Carreiro SP, Babu KM (2012) Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 8:15–32CrossRef
5.
go back to reference Shellard EJ (1989) Ethnopharmacology of kratom and the Mitragyna alkaloids. J Ethnopharmacol 25:123–124CrossRef Shellard EJ (1989) Ethnopharmacology of kratom and the Mitragyna alkaloids. J Ethnopharmacol 25:123–124CrossRef
7.
go back to reference Hassan Z, Muzaimi M, Navaratnam V et al (2013) From kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction. Neurosci Biobehav Rev 37:138–151CrossRef Hassan Z, Muzaimi M, Navaratnam V et al (2013) From kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction. Neurosci Biobehav Rev 37:138–151CrossRef
9.
go back to reference Beckett AH, Shellard EJ, Phillipson JD et al (1965) Alkaloids from Mitragyna speciosa (Korth.). J Pharm Pharmacol 17:753–755CrossRef Beckett AH, Shellard EJ, Phillipson JD et al (1965) Alkaloids from Mitragyna speciosa (Korth.). J Pharm Pharmacol 17:753–755CrossRef
10.
go back to reference Assanangkornchai S, Pattanasattayawong U, Samangsri N et al (2007) Substance use among high-school students in Southern Thailand: trends over 3 years (2002–2004). Drug Alcohol Depend 86:167–174CrossRef Assanangkornchai S, Pattanasattayawong U, Samangsri N et al (2007) Substance use among high-school students in Southern Thailand: trends over 3 years (2002–2004). Drug Alcohol Depend 86:167–174CrossRef
11.
go back to reference Boyer EW, Babu KM, Adkins JE et al (2008) Self-treatment of opioid withdrawal using kratom (Mitragyna speciosa Korth). Addiction 103:1048–1050CrossRef Boyer EW, Babu KM, Adkins JE et al (2008) Self-treatment of opioid withdrawal using kratom (Mitragyna speciosa Korth). Addiction 103:1048–1050CrossRef
12.
go back to reference Jansen KL, Prast CJ (1988) Ethnopharmacology of kratom and the Mitragyna alkaloids. J Ethnopharmacol 23:115–119CrossRef Jansen KL, Prast CJ (1988) Ethnopharmacology of kratom and the Mitragyna alkaloids. J Ethnopharmacol 23:115–119CrossRef
13.
go back to reference Parthasarathy S, Bin Azizi J, Ramanathan S et al (2009) Evaluation of antioxidant and antibacterial activities of aqueous, methanolic and alkaloid extracts from Mitragyna speciosa (Rubiaceae family) leaves. Molecules 14:3964–3974CrossRef Parthasarathy S, Bin Azizi J, Ramanathan S et al (2009) Evaluation of antioxidant and antibacterial activities of aqueous, methanolic and alkaloid extracts from Mitragyna speciosa (Rubiaceae family) leaves. Molecules 14:3964–3974CrossRef
14.
go back to reference Chan KB, Pakiam C, Rahim RA (2005) Psychoactive plant abuse: the identification of mitragynine in ketum and in ketum preparations. Bull Narc 57:249–256PubMed Chan KB, Pakiam C, Rahim RA (2005) Psychoactive plant abuse: the identification of mitragynine in ketum and in ketum preparations. Bull Narc 57:249–256PubMed
15.
go back to reference Forrester MB (2013) Kratom exposures reported to Texas poison centers. J Addict Dis 32:396–400CrossRef Forrester MB (2013) Kratom exposures reported to Texas poison centers. J Addict Dis 32:396–400CrossRef
16.
go back to reference Mowry JB, Spyker DA, Cantilena LR Jr et al (2014) 2013 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st annual report. Clin Toxicol (Phila) 52:1032–1283CrossRef Mowry JB, Spyker DA, Cantilena LR Jr et al (2014) 2013 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st annual report. Clin Toxicol (Phila) 52:1032–1283CrossRef
17.
go back to reference Ingsathit A, Woratanarat P, Anukarahanonta T et al (2009) Prevalence of psychoactive drug use among drivers in Thailand: a roadside survey. Accid Anal Prev 41:474–478CrossRef Ingsathit A, Woratanarat P, Anukarahanonta T et al (2009) Prevalence of psychoactive drug use among drivers in Thailand: a roadside survey. Accid Anal Prev 41:474–478CrossRef
18.
go back to reference Suttajit S, Kittirattanapaiboon P, Junsirimongkol B et al (2012) Risks of major depressive disorder and anxiety disorders among Thais with alcohol use disorders and illicit drug use: findings from the 2008 Thai National Mental Health survey. Addict Behav 37:1395–1399CrossRef Suttajit S, Kittirattanapaiboon P, Junsirimongkol B et al (2012) Risks of major depressive disorder and anxiety disorders among Thais with alcohol use disorders and illicit drug use: findings from the 2008 Thai National Mental Health survey. Addict Behav 37:1395–1399CrossRef
20.
go back to reference Babu KM, McCurdy CR, Boyer EW (2008) Opioid receptors and legal highs: Salvia divinorum and kratom. Clin Toxicol (Phila) 46:146–152CrossRef Babu KM, McCurdy CR, Boyer EW (2008) Opioid receptors and legal highs: Salvia divinorum and kratom. Clin Toxicol (Phila) 46:146–152CrossRef
21.
go back to reference Prozialeck WC, Jivan JK, Andurkar SV (2012) Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects. J Am Osteopath Assoc 112:792–799PubMed Prozialeck WC, Jivan JK, Andurkar SV (2012) Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects. J Am Osteopath Assoc 112:792–799PubMed
22.
go back to reference Philipp AA, Wissenbach DK, Weber AA et al (2010) Phase I and II metabolites of speciogynine, a diastereomer of the main kratom alkaloid mitragynine, identified in rat and human urine by liquid chromatography coupled to low- and high-resolution linear ion trap mass spectrometry. J Mass Spectrom 45:1344–1357CrossRef Philipp AA, Wissenbach DK, Weber AA et al (2010) Phase I and II metabolites of speciogynine, a diastereomer of the main kratom alkaloid mitragynine, identified in rat and human urine by liquid chromatography coupled to low- and high-resolution linear ion trap mass spectrometry. J Mass Spectrom 45:1344–1357CrossRef
23.
go back to reference Kapp FG, Maurer HH, Auwarter V et al (2011) Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa). J Med Toxicol 7:227–231CrossRef Kapp FG, Maurer HH, Auwarter V et al (2011) Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa). J Med Toxicol 7:227–231CrossRef
24.
go back to reference Takayama H (2004) Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa. Chem Pharm Bull (Tokyo) 52:916–928CrossRef Takayama H (2004) Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa. Chem Pharm Bull (Tokyo) 52:916–928CrossRef
25.
go back to reference Kong WM, Chik Z, Ramachandra M et al (2011) Evaluation of the effects of Mitragyna speciosa alkaloid extract on cytochrome P450 enzymes using a high throughput assay. Molecules 16:7344–7356CrossRef Kong WM, Chik Z, Ramachandra M et al (2011) Evaluation of the effects of Mitragyna speciosa alkaloid extract on cytochrome P450 enzymes using a high throughput assay. Molecules 16:7344–7356CrossRef
27.
go back to reference Neerman MF, Frost RE, Deking J (2013) A drug fatality involving kratom. J Forensic Sci 58(Suppl 1):S278–S279CrossRef Neerman MF, Frost RE, Deking J (2013) A drug fatality involving kratom. J Forensic Sci 58(Suppl 1):S278–S279CrossRef
28.
go back to reference Trakulsrichai S, Sathirakul K, Auparakkitanon S et al (2015) Pharmacokinetics of mitragynine in man. Drug Des Devel Ther 9:2421–2429PubMedPubMedCentral Trakulsrichai S, Sathirakul K, Auparakkitanon S et al (2015) Pharmacokinetics of mitragynine in man. Drug Des Devel Ther 9:2421–2429PubMedPubMedCentral
29.
go back to reference Scott TM, Yeakel JK, Logan BK (2014) Identification of mitragynine and O-desmethyltramadol in kratom and legal high products sold online. Drug Test Anal 6:959–963CrossRef Scott TM, Yeakel JK, Logan BK (2014) Identification of mitragynine and O-desmethyltramadol in kratom and legal high products sold online. Drug Test Anal 6:959–963CrossRef
30.
go back to reference Maruyama T, Kawamura M, Kikura-Hanajiri R et al (2009) The botanical origin of kratom (Mitragyna speciosa; Rubiaceae) available as abused drugs in the Japanese markets. J Nat Med 63:340–344CrossRef Maruyama T, Kawamura M, Kikura-Hanajiri R et al (2009) The botanical origin of kratom (Mitragyna speciosa; Rubiaceae) available as abused drugs in the Japanese markets. J Nat Med 63:340–344CrossRef
31.
go back to reference Janchawee B, Keawpradub N, Chittrakarn S et al (2007) A high-performance liquid chromatographic method for determination of mitragynine in serum and its application to a pharmacokinetic study in rats. Biomed Chromatogr 21:176–183CrossRef Janchawee B, Keawpradub N, Chittrakarn S et al (2007) A high-performance liquid chromatographic method for determination of mitragynine in serum and its application to a pharmacokinetic study in rats. Biomed Chromatogr 21:176–183CrossRef
33.
go back to reference Harizal SN, Mansor SM, Hasnan J et al (2010) Acute toxicity study of the standardized methanolic extract of Mitragyna speciosa Korth in rodent. J Ethnopharmacol 131:404–409CrossRef Harizal SN, Mansor SM, Hasnan J et al (2010) Acute toxicity study of the standardized methanolic extract of Mitragyna speciosa Korth in rodent. J Ethnopharmacol 131:404–409CrossRef
34.
go back to reference Chittrakarn S, Sawangjaroen K, Prasettho S et al (2008) Inhibitory effects of kratom leaf extract (Mitragyna speciosa Korth.) on the rat gastrointestinal tract. J Ethnopharmacol 116:173–178CrossRef Chittrakarn S, Sawangjaroen K, Prasettho S et al (2008) Inhibitory effects of kratom leaf extract (Mitragyna speciosa Korth.) on the rat gastrointestinal tract. J Ethnopharmacol 116:173–178CrossRef
35.
go back to reference Kronstrand R, Roman M, Thelander G et al (2011) Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton. J Anal Toxicol 35:242–247CrossRef Kronstrand R, Roman M, Thelander G et al (2011) Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton. J Anal Toxicol 35:242–247CrossRef
36.
go back to reference McWhirter L, Morris S (2010) A case report of inpatient detoxification after kratom (Mitragyna speciosa) dependence. Eur Addict Res 16:229–231CrossRef McWhirter L, Morris S (2010) A case report of inpatient detoxification after kratom (Mitragyna speciosa) dependence. Eur Addict Res 16:229–231CrossRef
37.
go back to reference Limsuwanchote S, Wungsintaweekul J, Keawpradub N et al (2014) Development of indirect competitive ELISA for quantification of mitragynine in kratom (Mitragyna speciosa (Roxb.) Korth.). Forensic Sci Int 244:70–77CrossRef Limsuwanchote S, Wungsintaweekul J, Keawpradub N et al (2014) Development of indirect competitive ELISA for quantification of mitragynine in kratom (Mitragyna speciosa (Roxb.) Korth.). Forensic Sci Int 244:70–77CrossRef
38.
go back to reference Wang M, Carrell EJ, Ali Z et al (2014) Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants. J Sep Sci 37:1411–1418CrossRef Wang M, Carrell EJ, Ali Z et al (2014) Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants. J Sep Sci 37:1411–1418CrossRef
39.
go back to reference Philipp AA, Meyer MR, Wissenbach DK et al (2011) Monitoring of kratom or Krypton intake in urine using GC-MS in clinical and forensic toxicology. Anal Bioanal Chem 400:127–135CrossRef Philipp AA, Meyer MR, Wissenbach DK et al (2011) Monitoring of kratom or Krypton intake in urine using GC-MS in clinical and forensic toxicology. Anal Bioanal Chem 400:127–135CrossRef
40.
go back to reference Lesiak AD, Cody RB, Dane AJ et al (2014) Rapid detection by direct analysis in real time-mass spectrometry (DART-MS) of psychoactive plant drugs of abuse: the case of Mitragyna speciosa aka “kratom”. Forensic Sci Int 242:210–218CrossRef Lesiak AD, Cody RB, Dane AJ et al (2014) Rapid detection by direct analysis in real time-mass spectrometry (DART-MS) of psychoactive plant drugs of abuse: the case of Mitragyna speciosa aka “kratom”. Forensic Sci Int 242:210–218CrossRef
43.
go back to reference Holler JM, Vorce SP, McDonough-Bender PC et al (2011) A drug toxicity death involving propylhexedrine and mitragynine. J Anal Toxicol 35:54–59CrossRef Holler JM, Vorce SP, McDonough-Bender PC et al (2011) A drug toxicity death involving propylhexedrine and mitragynine. J Anal Toxicol 35:54–59CrossRef
44.
go back to reference McIntyre IM, Trochta A, Stolberg S et al (2015) Mitragynine ‘kratom’ related fatality: a case report with postmortem concentrations. J Anal Toxicol 39:152–155CrossRef McIntyre IM, Trochta A, Stolberg S et al (2015) Mitragynine ‘kratom’ related fatality: a case report with postmortem concentrations. J Anal Toxicol 39:152–155CrossRef
50.
go back to reference Raffa RB (2014) Kratom and other mitragynines: the chemistry and pharmacology of opioids from a non-opium source. CRC, Boca RatonCrossRef Raffa RB (2014) Kratom and other mitragynines: the chemistry and pharmacology of opioids from a non-opium source. CRC, Boca RatonCrossRef
Metadata
Title
The pharmacology and toxicology of kratom: from traditional herb to drug of abuse
Authors
Marcus L. Warner
Nellie C. Kaufman
Oliver Grundmann
Publication date
01-01-2016
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Legal Medicine / Issue 1/2016
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-015-1279-y

Other articles of this Issue 1/2016

International Journal of Legal Medicine 1/2016 Go to the issue